These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 24976370)

  • 1. Review: [corrected] The changing face of the HIV epidemic in sub-Saharan Africa.
    Mutevedzi PC; Newell ML
    Trop Med Int Health; 2014 Sep; 19(9):1015-28. PubMed ID: 24976370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment acceleration program and the experience of the DREAM program in prevention of mother-to-child transmission of HIV.
    Palombi L; Marazzi MC; Voetberg A; Magid NA
    AIDS; 2007 Jul; 21 Suppl 4():S65-71. PubMed ID: 17620755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment as Prevention: Concepts and Challenges for Reducing HIV Incidence.
    Brault MA; Spiegelman D; Hargreaves J; Nash D; Vermund SH
    J Acquir Immune Defic Syndr; 2019 Dec; 82 Suppl 2(2):S104-S112. PubMed ID: 31658196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extent to which low-level use of antiretroviral treatment could curb the AIDS epidemic in sub-Saharan Africa.
    Wood E; Braitstein P; Montaner JS; Schechter MT; Tyndall MW; O'Shaughnessy MV; Hogg RS
    Lancet; 2000 Jun; 355(9221):2095-100. PubMed ID: 10902622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contemporary issues on the epidemiology and antiretroviral adherence of HIV-infected adolescents in sub-Saharan Africa: a narrative review.
    Adejumo OA; Malee KM; Ryscavage P; Hunter SJ; Taiwo BO
    J Int AIDS Soc; 2015; 18(1):20049. PubMed ID: 26385853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PrEP as a feature in the optimal landscape of combination HIV prevention in sub-Saharan Africa.
    McGillen JB; Anderson SJ; Hallett TB
    J Int AIDS Soc; 2016; 19(7(Suppl 6)):21104. PubMed ID: 27760682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Where to deploy pre-exposure prophylaxis (PrEP) in sub-Saharan Africa?
    Verguet S; Stalcup M; Walsh JA
    Sex Transm Infect; 2013 Dec; 89(8):628-34. PubMed ID: 23912819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The History of the HIV/AIDS Epidemic in Africa.
    Kagaayi J; Serwadda D
    Curr HIV/AIDS Rep; 2016 Aug; 13(4):187-93. PubMed ID: 27188298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.
    ; de Vincenzi I
    Lancet Infect Dis; 2011 Mar; 11(3):171-80. PubMed ID: 21237718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention in neglected subpopulations: prevention of mother-to-child transmission of HIV infection.
    Mofenson LM
    Clin Infect Dis; 2010 May; 50 Suppl 3():S130-48. PubMed ID: 20397941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can the Heterosexual HIV Epidemic be Eliminated in South Africa Using Combination Prevention? A Modeling Analysis.
    Abuelezam NN; McCormick AW; Fussell T; Afriyie AN; Wood R; DeGruttola V; Freedberg KA; Lipsitch M; Seage GR
    Am J Epidemiol; 2016 Aug; 184(3):239-48. PubMed ID: 27416841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors affecting adherence to short-course ARV prophylaxis for preventing mother-to-child transmission of HIV in sub-Saharan Africa: a review and lessons for future elimination.
    Colombini M; Stöckl H; Watts C; Zimmerman C; Agamasu E; Mayhew SH
    AIDS Care; 2014; 26(7):914-26. PubMed ID: 24354642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low prevalence of renal dysfunction in HIV-infected pregnant women: implications for guidelines for the prevention of mother-to-child transmission of HIV.
    Myer L; Kamkuemah M; Kaplan R; Bekker LG
    Trop Med Int Health; 2013 Nov; 18(11):1400-5. PubMed ID: 24102663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential utility of empirical tuberculosis treatment for HIV-infected patients with advanced immunodeficiency in high TB-HIV burden settings.
    Lawn SD; Ayles H; Egwaga S; Williams B; Mukadi YD; Santos Filho ED; Godfrey-Faussett P; Granich RM; Harries AD
    Int J Tuberc Lung Dis; 2011 Mar; 15(3):287-95. PubMed ID: 21333094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of ART on the fertility of HIV-positive women in sub-Saharan Africa.
    Yeatman S; Eaton JW; Beckles Z; Benton L; Gregson S; Zaba B
    Trop Med Int Health; 2016 Sep; 21(9):1071-85. PubMed ID: 27371942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination prevention: new hope for stopping the epidemic.
    Vermund SH; Hayes RJ
    Curr HIV/AIDS Rep; 2013 Jun; 10(2):169-86. PubMed ID: 23456730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opportunities and Challenges in HIV Treatment as Prevention Research: Results from the ANRS 12249 Cluster-Randomized Trial and Associated Population Cohort.
    Tanser F; Kim HY; Vandormael A; Iwuji C; Bärnighausen T
    Curr HIV/AIDS Rep; 2020 Apr; 17(2):97-108. PubMed ID: 32072468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbicides-emerging essential pillars of comprehensive HIV/AIDS prevention.
    Gaym A
    Ethiop Med J; 2006 Oct; 44(4):405-15. PubMed ID: 17370443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationale and evidence for human immunodeficiency virus treatment as prevention at the individual and population levels.
    Hoffmann CJ; Gallant JE
    Infect Dis Clin North Am; 2014 Dec; 28(4):549-61. PubMed ID: 25287588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incorporating loss to follow-up in estimates of survival among HIV-infected individuals in sub-Saharan Africa enrolled in antiretroviral therapy programs.
    Verguet S; Lim SS; Murray CJ; Gakidou E; Salomon JA
    J Infect Dis; 2013 Jan; 207(1):72-9. PubMed ID: 23100567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.